IPSS trends for Cs-131 permanent prostate brachytherapy
Authors: Andrew Jones, Ph.D., Jared Treas, M.S., John Danella, M.D., Omar Yumen, M.D.
Published: 01/04/2008

“Cesium provides everything we want for prostate brachytherapy as both a monotherapy and in combination therapy, including delivery of a high dose of radiation more quickly for high risk patients in a low dose rate ‘setting.’” 

Dr. Bernard W. Taylor, MD

Texas Oncology - Longview Cancer Center